Global Preimplantation Genetic Screening Market Trends, Business Overview, Industry Growth and Forecast to 2022-2028

The global preimplantation genetic screening market is anticipated to grow at a considerable CAGR of 10.2% during the forecast period (2022-2028). Preimplantation genetic screening is the process of genetic screening used in analyzing and evaluating embryos before transfer to the uterus. The screening is done using several different methods, including NGS, PCR, FISH, CGH, and Others. The major factor attributing to the growth of the global preimplantation genetic screening market includes the application of genetic screening for aneuploidy in people. According to the National Center for Biotechnology Information (NCBI), aneuploidy is a rare condition represented by the presence of an abnormal number of sex chromosomes affecting around one in every 400 to one in every 1,000 people across the globe.

The application of preimplantation genetic screening is also increasing for the detection of single-gene disorder in people. According to the article published by the YourGenome, the single-gene disorder is a very rare condition represented by the mutated version of the gene responsible for the disorder. An estimation of around 1% of the global population is affected by a single-gene disorder. Furthermore, the application of preimplantation genetic screening is also increasing for several other purposes, including the detection of human leukocytes, structural chromosome abnormalities, X-linked disorders, and gender identity before birth as it offers several benefits, such as less uncertainty, improved embryo selection, gender selection during fertilization, prevention of various abnormal genetic transmissions, optimized chance of getting pregnant, and identification of fertility treatment.

(Get 15% Discount on Buying this Report)

Get Sample Copy of Global Preimplantation Genetic Screening Market at:
https://orionmarketreports.com/request-sample/?id=104929&submit=Request+Sample%0D%0A

Market Coverage
• The market number available for - 2021-2028
• Base year- 2021
• Forecast period- 2022-2028

• Segment Covered-
o By Technology
o By Application

• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World

• Competitive Landscape- Thermo Fisher Scientific Inc., Illumina Inc., Agilent Technologies Inc., PerklinElmer Inc., and Abbott, among others.

Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

A full report of Global Preimplantation Genetic Screening Market is available at:
https://orionmarketreports.com/global-preimplantation-genetic-screening-market/104929/

Global Preimplantation Genetic Screening Market Report by Segment

By Technology
• Next-Generation Sequencing (NGS)
• Polymerase Chain Reaction (PCR)
• Fluorescence In Situ Hybridization (FISH)
• Comparative Genomic Hybridization (CGH)
• Single Nucleotide Polymorphism (SNP)

By Application
• Aneuploidy
• Single Gene Disorder
• Structural Chromosome Abnormalities
• X-Linked Disorder
• Human Leukocyte
• Gender Identification

Company name: Orion Market Reports
Contact person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404

About us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

This release was published on openPR.